These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 2753818
1. N-salicylidene derivatives of pirarubicin. Ajito K, Ikeda D, Komuro K, Nosaka C, Wako N, Kondo S, Takeuchi T. J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818 [Abstract] [Full Text] [Related]
2. Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin. Ajito K, Ikeda D, Nosaka C, Komuro K, Kondo S, Takeuchi T. J Antibiot (Tokyo); 1990 Nov; 43(11):1464-70. PubMed ID: 2272921 [Abstract] [Full Text] [Related]
3. 3'-Hydroxyesorubicin. Synthesis and antitumor activity. Priebe W, Neamati N, Perez-Soler R. J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778 [Abstract] [Full Text] [Related]
10. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A. Rose WC, Schurig JE, Huftalen JB, Bradner WT. Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399 [No Abstract] [Full Text] [Related]
11. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334). Johnson RK, Ovejera AA, Goldin A. Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316 [No Abstract] [Full Text] [Related]
12. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26. Chiuten DF, Muggia FM, Johnson RK. Cancer Treat Rep; 1979 Jan; 63(11-12):1857-62. PubMed ID: 93512 [No Abstract] [Full Text] [Related]